Did you know that Atrial Fibrillation (AFib) patients are 5x more likely to have a stroke? IQVIA Healthcare-grade AI™ can help predict likelihood of stroke in at-risk patients, enabling them to take steps to prevent it. Learn more about the power of healthcare-grade AI at https://bit.ly/4cNgNzx
IQVIA
Hospitals and Health Care
Durham, North Carolina 2,056,505 followers
Accelerate innovation for a healthier world.
About us
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 86,000 employees, IQVIA conducts operations in more than 100 countries. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
Join our panel of speakers in this live webinar tomorrow as they discuss how to maximise biopharma valuations, considering investors’ prior expectations, development phase at readout, therapy area, and trial design. Register now to secure your spot. https://bit.ly/3zMCnph #biotech #emergingbiopharma
-
On the hunt for a fulfilling career as a #ClinicalResearchAssociate? Here are six essential skills to consider for a successful #CRA career at IQVIA: https://bit.ly/3WqYFpz #WeAreIQVIA
-
Join our July 24 webinar to explore how real world studies can be used to holistically capture patient experiences and outcomes in clinical settings. IQVIA’s Christina Mack, Matt Reaney, Ian Bonzani, Emily Wentzell and Andy Graves, will discuss and provide their insights into patient centricity across measurement science, behavioral science, operations and health technology. Listen to the conversation and understand the opportunities to incorporate patient-centric designs into real world research. https://bit.ly/4bLJ0p7 #RWE
-
Discover how IQVIA’s Lifecycle Management (LCM) Services created a 30% cost-saving for a pharma customer.
Do you need help balancing new product development to drive growth while managing regulatory compliance of mature products? Are you looking for a cost-effective and flexible solution that combines 3,300+ global regulatory experts with AI/ML technology? IQVIA’s Lifecycle Management (LCM) Services blends human expertise, technological flexibility, and strategic insights to offer a comprehensive suite of solutions tailored for seamless navigation and adaptability in evolving regulatory landscapes. Discover how IQVIA’s LCM services created a 30% cost-saving for a pharma customer: https://bit.ly/3LnLGhL #LifecycleMaintenance #RegulatoryLabeling #RegulatoryOperations
-
Check out this newly published report featuring a Clinical Trial Readiness Analysis developed by the IQVIA Institute that allows for ranking of countries by trial type, and surfaces near- and long-term opportunities for investment and improvement in country utilization.
🔍 New report out now: Rethinking Clinical Trial Country Prioritization The biopharma clinical research ecosystem has undergone significant evolution over the past five years due to technological, environmental, societal, regulatory, and geopolitical shifts. These changes have reshaped clinical trial activities and operations, bringing both opportunities and challenges. 📊 Our latest report explores: ✅ The emergence of new global players in clinical trials. ✅ Execution challenges, delays, capacity concerns, and uncertainties impacting clinical development timelines and patient outcomes. ✅ The critical focus on global diversification of clinical trials. ✅ Trends in enrollment timelines, trial characteristics, and country utilization. ✅ Exploration of countries with high patient recruitment potential. Get your copy of the report: https://lnkd.in/erWtB-qG #ClinicalTrials #GlobalHealth #HealthEquity
-
IQVIA Transparency Reporting is helping LEO Pharma, a global company dedicated to advancing the standard of care for the benefit of people with skin conditions, keep up with consistently changing global transparency legislations, regulations, and codes, which is a major challenge for life sciences companies of all sizes. IQVIA’s Transparency Reporting makes reporting seamless with a user-friendly, intuitive process, and best-in-class SaaS technology, combined with continuous legal monitoring expertise that provides regulatory updates to stay compliant. “LEO Pharma utilizes IQVIA's Transparency Reporting solution to streamline our global transparency reporting process, significantly reducing the time and resources previously devoted to the reporting process. The advanced analytics and user-friendly dashboards have empowered us to focus more on strategic growth while ensuring compliance with changing global regulations.” said the Head of HCP Compliance at LEO Pharma. LEO Pharma uses IQVIA’s Transparency Reporting solution to meet global transparency requirements across 22 countries. With this robust SaaS solution, the company can streamline their data integration from all sources, remediate and manage spend with in depth reporting tools, and utilize robust analytics to drive greater compliance insights, all on a single platform. For more information on IQVIA Transparency Reporting, visit https://bit.ly/4bLMCY1.
-
Are you planning for evidence generation and dissemination early enough in your product’s lifecycle? Partner with IQVIA Medical Affairs to advance healthcare decision-making that improves patient outcomes. https://bit.ly/3zEQj4z #medaffairs
-
We are excited to announce that Everest Group has recognized IQVIA as a Leader in Life Sciences Regulatory and Medical Affairs Operations. #IQVIANewsroom “IQVIA is honored to be recognized for its role in enabling our medical affairs and regulatory customers to close the gap between medical knowledge and medical practice to improve patients’ lives” said Rob Kotchie, president, Real World Solutions, IQVIA. Read the full press release here: https://bit.ly/3WhxpcM
-
In this new article published by Applied Clinical Trials Magazine, IQVIA’s Matt Reaney, Rachel Bruce, Kim Kelly, and Lindsay Hughes propose a 3-part framework for a more comprehensive conceptual model of patient experience that can provide a more rounded understanding of patient experiences in clinical trials and beyond. https://bit.ly/3y4nZYO
Affiliated pages
Similar pages
Browse jobs
Stock
IQV
NYSE
20 minutes delay
$232.95
7.06 (3.125%)
- Open
- 227.83
- Low
- 227.37
- High
- 234.33
Data from Refinitiv
See more info on